Vanessa Jones
Adult Health · Mobile, ALNPI 1710388509
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,663 and has fallen 95.6% since, to $117 in 2025.
Across 221 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$507
- Novartis$442
- AstraZeneca$382
- Eisai Inc.$243
- Bristol Myers Squibb$242
- Regeneron Healthcare Solutions, Inc.$229
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,04797%
- Education$1163%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $507 |
| Novartis | 27 | $442 |
| AstraZeneca | 15 | $382 |
| Eisai Inc. | 15 | $243 |
| Bristol Myers Squibb | 12 | $242 |
| Regeneron Healthcare Solutions, Inc. | 10 | $229 |
| Merck | 14 | $215 |
| Lilly USA, LLC | 6 | $186 |
| Amgen | 13 | $185 |
| Epizyme, Inc. | 4 | $174 |
| Daiichi Sankyo Inc. | 10 | $170 |
| Beigene USA, Inc. | 4 | $141 |
| AbbVie | 5 | $134 |
| Pfizer | 8 | $132 |
| Sanofi | 6 | $98 |
| Exelixis Inc. | 4 | $80 |
| Incyte Corporation | 4 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Sobi, Inc | 4 | $58 |
| Seagen Inc. | 3 | $47 |
| AVEO Pharmaceuticals, Inc. | 3 | $45 |
| Array Biopharma Inc | 2 | $42 |
| Tersera Therapeutics LLC | 2 | $40 |
| Stemline Therapeutics Inc. | 2 | $37 |
| GSK | 2 | $36 |
| Karyopharm Therapeutics Inc. | 2 | $28 |
| Blueprint Medicines Corporation | 2 | $28 |
| Myovant Sciences Inc. | 2 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,163 in reported general payments places this provider in the 85th percentile of 308 adult health providers in Alabama.
Other adult health in Mobile
- Virginia RudolfMobile$6K
- Mary SmithMobile$4K
- Hannah SmithMobile$4K
- Wendy CantrellMountain Brk$276K
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Olivia ViseHoover$15K
- Lindsay SmithPelham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.